TP53 and neoplasm: All mutations were missense mutations in the DNA binding domain of TP53. In all cases, tumor tissues showed high variant allele frequencies (VAFs) of TP53 (range: 78.3–92.4%), while copy number alteration of TP53 gene in tumor-derived DNA was not detected.